The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.
about
Smoking cessation strategies for patients with asthma: improving patient outcomesThe asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?Benralizumab: a unique IL-5 inhibitor for severe asthmaAsthma-COPD overlap syndrome (ACOS): A diagnostic challengeClinical characteristics of the asthma-COPD overlap syndrome--a systematic reviewNew combination treatments in the management of asthma: focus on fluticasone/vilanterolVirus-induced exacerbations in asthma and COPDAsthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insightsSpotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyCharacteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological studyDiagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Feasibility and effectiveness of an asthma/COPD service for primary care: a cross-sectional baseline description and longitudinal results.Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients: a population-based cohort study.Biomarker-based detection of asthma-COPD overlap syndrome in COPD populationsApplying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practiceThe Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe.Asthma-Chronic Obstructive Pulmonary Diseases Overlap Syndrome Increases the Risk of Incident Tuberculosis: A National Cohort StudyImpact of lung function on exacerbations, health care utilization, and costs among patients with COPDThe objective evaluation of obstructive pulmonary diseases with spirometryIdentifying possible asthma-COPD overlap syndrome in patients with a new diagnosis of COPD in primary care.Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review.COPD updates: what's new in pathophysiology and management?Pharmacotherapy of critical asthma syndrome: current and emerging therapies.Evaluation and treatment of critical asthma syndrome in children.Safety considerations of inhaled corticosteroids in the elderly.The acute management of asthma.The asthma COPD overlap syndrome (ACOS).Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.Treatment of severe asthma: entering the era of targeted therapy.Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases.The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence.Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy.Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?Real-world asthma management with inhaler devices in Switzerland-results of the asthma survey.
P2860
Q26738499-B11FB5CC-E040-40BD-8F4D-8873CF3F955FQ26745760-CF473E37-205C-4DA2-9A76-AD58F55B2D46Q26750711-DE026E29-A43E-4911-83B4-C082C4947012Q26785749-D255742A-13A0-4006-9750-1177F8259764Q26801310-1E4DBC9F-AC66-42D9-A037-31889DAA3568Q26852898-3FD5D8A2-A78F-4C36-84BF-F2A7DA143546Q27008731-67E00AA9-B8C6-41ED-8B48-5A3C3E4CE128Q28068805-F5D40AEB-05AA-4D99-9573-A4AD6B87008CQ28074802-D1D9D251-B21C-4D5C-92A7-D498291623A7Q31042074-335D2D77-0589-4D0D-B2B5-5512680AF91EQ34945947-353F72DF-738C-488C-B952-E874E6071302Q35538249-5AF8660B-28A5-434B-BB31-29EE7CB49EB7Q35939326-157B8F50-AD6D-41CA-BD10-E9EB201CEEE8Q36036910-F2D4DD84-92D2-44B0-AC98-AE5198B90E70Q36153811-5AFBD4F2-A859-48AB-8515-B207F4261F2DQ36170537-5A399E05-A9E7-48FC-8D8C-08133E6BC62BQ36332206-9531FCAF-AB7A-497B-AFC0-A8E4A157090DQ36566081-F3C17D7A-21F1-4C76-BAAD-2B46DD7059D5Q36733544-2B1208A5-6EB7-4531-BD1F-75FEE50BC5C2Q37119217-154E643A-C855-4D11-9DA3-8807FA357F7CQ37142609-A04024AF-30E9-4639-9052-A38B2509A528Q37225790-D55E12F7-1042-4AF6-BB54-C8F74ACAFB1EQ37559047-1273C884-1DAE-4145-9D28-2029CD7844BDQ37663904-9017C57D-A02F-4D8F-BC84-ADB1441E86A9Q38130515-DD4CA175-3FF4-4EB9-B3F9-2962933CEEB5Q38157770-20A4B975-A3BA-4D67-90AA-8F5C86AC5FF0Q38184431-EF616CE8-8C66-436A-BF0D-D6D9E2819665Q38248458-EC520AFE-9A56-48D9-8E1D-691697AEB4D3Q38248502-5AF11880-B25F-4D61-83AD-0DEDB22F048DQ38364870-67A8B29F-604B-4329-94BF-F7F671688486Q38498038-FC62A73D-DC1C-423C-90F4-18442DFCA432Q38578918-250714E6-3F82-40FE-8087-3AC4E29CB560Q38644007-D62F50D7-EB2A-4BA1-8019-4D0BC3A5E902Q38669520-9E7DA757-AED3-43A0-B3EA-264B3773F5C6Q38681962-41FE2ADA-925E-42DD-8101-EDE776D619AAQ38827675-05C42412-0FEA-4291-9279-0160DF1DE881Q39173650-885FF0A9-4E62-42D4-868B-EC943986CEC7Q39192905-635ADC11-4CAD-4A50-BC14-C78CCA8B0111Q39511855-DD612082-5F6B-4B68-8A19-D1B4CFA38CB0Q39718792-9A9044E7-2761-4E1B-BFB7-EABD4AA3D0C8
P2860
The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The asthma-chronic obstructive ...... acotherapeutic considerations.
@en
type
label
The asthma-chronic obstructive ...... acotherapeutic considerations.
@en
prefLabel
The asthma-chronic obstructive ...... acotherapeutic considerations.
@en
P2093
P2860
P356
P1476
The asthma-chronic obstructive ...... acotherapeutic considerations.
@en
P2093
Amir A Zeki
Andrew L Chan
Brian M Morrissey
Ken Y Yoneda
Mark Avdalovic
Michael Schivo
Samuel Louie
Timothy E Albertson
P2860
P304
P356
10.1586/ECP.13.2
P407
P577
2013-03-01T00:00:00Z